» Articles » PMID: 38077626

Correlation Between Human Gut Microbiome and Diseases

Overview
Date 2023 Dec 11
PMID 38077626
Authors
Affiliations
Soon will be listed here.
Abstract

Human gut microbiome is a major source of human bacterial population and a significant contribution to both positive and harmful effects. Due to its involvement in a variety of interactions, gut microorganisms have a great impact on our health throughout our lives. The impact of gut microbial population is been studied intensively in last two decades. Extensive literature survey focusing developments in the field were searched in English language Electronic Databases like PubMed, Google Scholar, Pubag, Google books, and Research Gate were mostly used to understand the role of human gut mirobiome and its role in different human diseases. Gut microbiome in healthy subjects differs from those who suffer from diseases. Type 2 diabetes, obesity, non-alcoholic liver disease, and cardiometabolic diseases have all been linked to dysbiosis of the gut microbiota. Pathogenesis of many disorders is also linked to changes in gut microbiota. Other diseases like cancer, arithritis, autism, depression, anxiety, sleep disorder, HIV, hypertension, and gout are also related to gut microbiota dysbiosis. We focus in this review on recent studies looking into the link between gut microbiome dysbiosis and disease etiology. Research on how gut microbiota affects host metabolism has been changed in past decades from descriptive analyses to high throughput integrative omics data analysis such as metagenomics and metabolomics. Identification of molecular mechanisms behind reported associations is been carried out in human, animals, and cells for measure of host physiology and mechanics. Still many the mechanisms are not completely understood.

Citing Articles

The Role of Gut Microbiota Dysbiosis in Erectile Dysfunction: From Pathophysiology to Treatment Strategies.

Kaltsas A, Giannakodimos I, Markou E, Adamos K, Stavropoulos M, Kratiras Z Microorganisms. 2025; 13(2).

PMID: 40005617 PMC: 11857656. DOI: 10.3390/microorganisms13020250.


Lifecourse research in cancer: context, challenges, and opportunities when exploring exposures in early life and cancer risk in adulthood.

Baker J, Gordon-Dseagu V, Voortman T, Chan D, Herceg Z, Robinson S Health Open Res. 2025; 6:16.

PMID: 39974286 PMC: 11836561. DOI: 10.12688/healthopenres.13748.2.


Unlocking the secrets of the human gut microbiota: Comprehensive review on its role in different diseases.

Paul J, Azmal M, Haque A, Meem M, Talukder O, Ghosh A World J Gastroenterol. 2025; 31(5):99913.

PMID: 39926224 PMC: 11718612. DOI: 10.3748/wjg.v31.i5.99913.


Gut Microbiota-Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer.

Said S, Ibrahim W Cancer Manag Res. 2025; 17:171-192.

PMID: 39881948 PMC: 11776928. DOI: 10.2147/CMAR.S405590.


Antimicrobial resistance of Escherichia coli in cats and their drinking water: drug resistance profiles and antimicrobial-resistant genes.

Sattasathuchana P, Srikullabutr S, Kerdsin A, Assawarachan S, Amavisit P, Surachetpong W BMC Vet Res. 2024; 20(1):573.

PMID: 39707426 PMC: 11660686. DOI: 10.1186/s12917-024-04435-8.


References
1.
Tremlett H, Bauer K, Appel-Cresswell S, Finlay B, Waubant E . The gut microbiome in human neurological disease: A review. Ann Neurol. 2017; 81(3):369-382. DOI: 10.1002/ana.24901. View

2.
Woodmansey E . Intestinal bacteria and ageing. J Appl Microbiol. 2007; 102(5):1178-86. DOI: 10.1111/j.1365-2672.2007.03400.x. View

3.
Jakobsson H, Jernberg C, Andersson A, Sjolund-Karlsson M, Jansson J, Engstrand L . Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One. 2010; 5(3):e9836. PMC: 2844414. DOI: 10.1371/journal.pone.0009836. View

4.
Du D, Tang W, Zhou C, Sun X, Wei Z, Zhong J . Fecal Microbiota Transplantation Is a Promising Method to Restore Gut Microbiota Dysbiosis and Relieve Neurological Deficits after Traumatic Brain Injury. Oxid Med Cell Longev. 2021; 2021:5816837. PMC: 7894052. DOI: 10.1155/2021/5816837. View

5.
Marrs T, Walter J . Pros and cons: Is faecal microbiota transplantation a safe and efficient treatment option for gut dysbiosis?. Allergy. 2021; 76(7):2312-2317. DOI: 10.1111/all.14750. View